UK company to acquire Perrigo for $20 billion
The pharmaceutical company’s share price is up 9.1% on the TASE after reports that an unnamed UK company will acquire it for $20 billion. Streetinsider.com said yestarday that the US drugmaker More...
Mylan-targeted Perrigo held merger talks with Endo -sources
Perrigo Company Plc, the Irish-based generic drugmaker trying to fend off a hostile bid by Mylan NV, held unsuccessful talks to acquire Endo International Plc in an all-stock deal, according More...
U.S. Court Denies Perrigo’s Attempt to Block Mylan’s Takeover Bid
Mylan N.V., which made a hostile takeover bid for Perrigo Co., said Friday that a U.S. District court denied Perrigo’s attempt to block the potential closing of Mylan’s proposed offer before shareholders. The More...
Mylan might make do with only 50% of Perrigo
Generic pharmaceutical company Mylan N.V. (MYL) today officially announced a reduction in the approval requirement for the Perrigo Company (NYSE:PRGO; TASE:PRGO) deal from 80% to 50%. This means that More...
Three Way Takeover Battle: Teva set to buy Allergan’s generics unit – WSJ
Teva likely mean the end of Teva’s pursuit of another Teva Pharmaceutical Industries Ltd. likely mean the end of pursuit of Mylan acquisition. The Israeli world’s biggest generic pharmaceutical maker More...
Three ways takeover battle: Mylan invokes “poison pill” to block Teva hostile takeover
Dutch Stichting Foundation notified Mylan that it has exercised its call option to acquire 488, 388, 431 Mylan preferred shares pursuant to the Call Option Agreement, dated April 3, 2015, between More...
Three Way Takeover Battle: Teva Completes the Purchase of 4.61 Percent Interest in Mylan N.V.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has completed first step to buy its rival Mylan N.V. (Nasdaq: MYL). The Israeli giant announced on Friday that it has completed the purchase of a 4.61% More...
Three Way Takeover Battle: Teva’s Mylan stake up to 4.3%
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) continues to accumulate shares in takeover target Mylan (MYL), even as Mylan’s largest shareholder, Abbott Labs (NYSE: ABT), announced More...
Three Way Takeover Battle: Mylan to list on TASE if Perrigo bid succeeds
One of the main worries of Tel Aviv Stock Exchange (TASE) leaders recently has been the expected delisting of Perrigo Company (NYSE:PRGO; TASE:PRGO), if and when the company’s acquisition by Mylan More...
Three Way Takeover Battle: Statistics weigh against Teva’s Mylan bid succeeding
Will drug company Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) succeed in its attempted hostile takeover of rival Mylan (MYL), or will it be Mylan that succeeds in its own hostile takeover More...